Advanced glycation end products and protein carbonyl levels in plasma reveal sex-specific differences in Parkinson's and Alzheimer's disease
Open Access
- 18 May 2020
- journal article
- research article
- Published by Elsevier BV in Redox Biology
- Vol. 34, 101546
- https://doi.org/10.1016/j.redox.2020.101546
Abstract
No abstract availableKeywords
Funding Information
- German Federal Ministry of Education and Research (# 01KU1403B)
This publication has 34 references indexed in Scilit:
- Glycation exacerbates the neuronal toxicity of β-amyloidCell Death & Disease, 2013
- Advanced glycation endproducts and their receptor RAGE in Alzheimer's diseaseNeurobiology of Aging, 2011
- Nɛ-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse modelBiochimie, 2010
- Redox Proteomic Analysis of Carbonylated Brain Proteins in Mild Cognitive Impairment and Early Alzheimer's DiseaseAntioxidants and Redox Signaling, 2010
- Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's diseaseNeuroscience Letters, 2010
- Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosisJournal of Neuroinflammation, 2010
- Pentosidine and Nε-(carboxymethyl)-lysine in Alzheimer’s disease and vascular dementiaNeurobiology of Aging, 2003
- The Swedish APP670/671 Alzheimer’s Disease Mutation: The First Evidence for Strikingly Increased Oxidative Injury in the Temporal Inferior CortexDementia and Geriatric Cognitive Disorders, 2001
- Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?Journal of Chemical Neuroanatomy, 2000
- Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative StressJournal of Neurochemistry, 1986